Kestra Medical Technologies Stock Analysis

KMTS Stock   26.80  1.33  5.22%   
At this time, Kestra Medical's Net Debt To EBITDA is comparatively stable compared to the past year. Total Debt To Capitalization is likely to gain to 0.21 in 2026, whereas Short and Long Term Debt Total is likely to drop slightly above 33.4 M in 2026. Kestra Medical's financial risk is the risk to Kestra Medical stockholders that is caused by an increase in debt.
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.13
Current Value
0.13
Quarterly Volatility
0.38274777
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
At this time, Kestra Medical's Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 357.1 M in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 39.6 M in 2026. . Price To Sales Ratio is likely to drop to 21.77 in 2026. Price Earnings Ratio is likely to drop to -9.9 in 2026.
Kestra Medical Technologies is fairly valued with Real Value of 25.11 and Target Price of 29.0. The main objective of Kestra Medical stock analysis is to determine its intrinsic value, which is an estimate of what Kestra Medical Technologies is worth, separate from its market price. There are two main types of Kestra Medical's stock analysis: fundamental analysis and technical analysis.
The Kestra Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Kestra Medical is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Kestra Stock trading window is adjusted to America/New York timezone.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kestra Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty.

Kestra Stock Analysis Notes

About 86.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.96. Kestra Medical Techn had not issued any dividends in recent years. To find out more about Kestra Medical Technologies contact the company at 425 279 8002 or learn more at https://kestramedical.com.

Kestra Medical Quarterly Total Revenue

22.57 Million

Kestra Medical Techn Investment Alerts

Kestra Medical Techn generated a negative expected return over the last 90 days
Kestra Medical Techn has high historical volatility and very poor performance
The company reported the previous year's revenue of 59.81 M. Net Loss for the year was (113.81 M) with profit before overhead, payroll, taxes, and interest of 34.46 M.
Kestra Medical generates negative cash flow from operations
Over 86.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Kestra Medical Technologies Stock Analysis Exploring A 16 percent Potential Upside - DirectorsTalk Interviews

Kestra Largest EPS Surprises

Earnings surprises can significantly impact Kestra Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-12-11
2025-10-31-0.57-0.64-0.0712 
2025-09-12
2025-07-31-0.776-0.50.27635 
2025-07-15
2025-04-30-0.53-1.0595-0.529599 
View All Earnings Estimates

Kestra Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.49 B.

Kestra Profitablity

The company has Profit Margin (PM) of (1.78) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.41) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.41.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.35)(0.36)
Return On Capital Employed(0.37)(0.39)
Return On Assets(0.35)(0.36)
Return On Equity(0.50)(0.52)

Management Efficiency

Kestra Medical Techn has return on total asset (ROA) of (0.4395) % which means that it has lost $0.4395 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.264) %, meaning that it created substantial loss on money invested by shareholders. Kestra Medical's management efficiency ratios could be used to measure how well Kestra Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.36 in 2026. Return On Capital Employed is likely to drop to -0.39 in 2026. At this time, Kestra Medical's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 48.8 M in 2026, whereas Return On Tangible Assets are likely to drop (0.36) in 2026.
Last ReportedProjected for Next Year
Book Value Per Share 3.73  3.92 
Tangible Book Value Per Share 3.73  3.92 
Enterprise Value Over EBITDA(9.17)(9.63)
Price Book Value Ratio 6.67  6.34 
Enterprise Value Multiple(9.17)(9.63)
Price Fair Value 6.67  6.34 
Enterprise Value1.1 B1.2 B
Understanding the operational decisions made by Kestra Medical management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Operating Margin
(1.41)
Profit Margin
(1.78)
Return On Assets
(0.44)
Return On Equity
(1.26)

Technical Drivers

As of the 9th of February, Kestra Medical secures the Downside Deviation of 3.93, risk adjusted performance of 0.0112, and Mean Deviation of 2.47. Kestra Medical Technologies technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kestra Medical Techn information ratio and downside variance to decide if Kestra Medical Technologies is priced some-what accurately, providing market reflects its recent price of 26.8 per share. Given that Kestra Medical Techn has jensen alpha of (0.08), we recommend you to check Kestra Medical's last-minute market performance to make sure the company can sustain itself at a future point.

Kestra Medical Techn Price Movement Analysis

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Kestra Medical price series with the more recent values given greater weights.

Kestra Medical Techn Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kestra Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kestra Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Kestra Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Kestra Medical Outstanding Bonds

Kestra Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Kestra Medical Techn uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Kestra bonds can be classified according to their maturity, which is the date when Kestra Medical Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Kestra Medical Predictive Daily Indicators

Kestra Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Kestra Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Kestra Medical Corporate Filings

F4
20th of January 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
31st of December 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
11th of December 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
4th of December 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
3rd of December 2025
Other Reports
ViewVerify
2nd of December 2025
Other Reports
ViewVerify
8K
1st of December 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
10th of November 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Kestra Medical Forecast Models

Kestra Medical's time-series forecasting models are one of many Kestra Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kestra Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Kestra Medical Bond Ratings

Kestra Medical Technologies financial ratings play a critical role in determining how much Kestra Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Kestra Medical's borrowing costs.
Piotroski F Score
6
HealthyView
Beneish M Score
(3.29)
Unlikely ManipulatorView

Kestra Medical Total Assets Over Time

Kestra Medical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Kestra Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Kestra Medical Debt Ratio

    
  13.0   
It appears most of the Kestra Medical's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Kestra Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Kestra Medical, which in turn will lower the firm's financial flexibility.

Kestra Medical Corporate Bonds Issued

Kestra Short Long Term Debt Total

Short Long Term Debt Total

33.42 Million

At this time, Kestra Medical's Short and Long Term Debt Total is comparatively stable compared to the past year.

About Kestra Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Kestra Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kestra shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Kestra Medical. By using and applying Kestra Stock analysis, traders can create a robust methodology for identifying Kestra entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(1.71)(1.80)
Operating Profit Margin(1.60)(1.68)
Net Loss(1.71)(1.80)
Gross Profit Margin 0.36  0.38 

Current Kestra Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Kestra analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Kestra analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceConsensus# of Analysts
29.0Strong Buy6Odds
Kestra Medical Technologies current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Kestra analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Kestra stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Kestra Medical Techn, talking to its executives and customers, or listening to Kestra conference calls.
Kestra Analyst Advice Details

Kestra Stock Analysis Indicators

Kestra Medical Technologies stock analysis indicators help investors evaluate how Kestra Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Kestra Medical shares will generate the highest return on investment. By understating and applying Kestra Medical stock analysis, traders can identify Kestra Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow8.6 M
Long Term Debt41.1 M
Common Stock Shares Outstanding49.5 M
Total Stockholder Equity205.4 M
Total Cashflows From Investing Activities-23.3 M
Tax Provision135 K
Property Plant And Equipment Net36.9 M
Cash And Short Term Investments237.6 M
Cash237.6 M
Accounts Payable24 M
Net Debt-193.3 M
50 Day M A25.3228
Total Current Liabilities38 M
Other Operating Expenses166.2 M
Non Current Assets Total40.4 M
Non Currrent Assets Other3.5 M
Stock Based Compensation24.3 M

Additional Tools for Kestra Stock Analysis

When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.